nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 23rd, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
494.0
|
4740
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 23rd, 2022 05:57AM
|
May 23rd, 2022 05:57AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 22nd, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4740
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 22nd, 2022 05:58AM
|
May 22nd, 2022 05:58AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 21st, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4739
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 21st, 2022 05:57AM
|
May 21st, 2022 05:57AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 20th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4738
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 20th, 2022 06:21AM
|
May 20th, 2022 06:21AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 18th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4737
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 18th, 2022 07:16AM
|
May 18th, 2022 07:16AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 17th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4736
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 17th, 2022 07:42AM
|
May 17th, 2022 07:42AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 15th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4736
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 15th, 2022 07:04AM
|
May 15th, 2022 07:04AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 14th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4736
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
250.00
|
About two weeks
|
274.00
|
MEDIUM
|
290.00
|
FAVORABLE
|
|
|
|
May 14th, 2022 07:00AM
|
May 14th, 2022 07:00AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 13th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
|
73.0
|
73.0
|
493.0
|
4735
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
249.00
|
About two weeks
|
273.00
|
MEDIUM
|
289.00
|
FAVORABLE
|
|
|
|
May 13th, 2022 06:51AM
|
May 13th, 2022 06:51AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
May 12th, 2022 12:00AM
|
Open
|
GlaxoSmithKline
|
|
Healthcare
|
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
|
Emma Walmsley
|
|
|
4.20
|
73.0
|
72.0
|
74.0
|
75.0
|
68.0
|
68.0
|
66.0
|
73.0
|
65.0
|
69.0
|
68.0
|
73.0
|
73.0
|
493.0
|
4734
|
4700
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
249.00
|
About two weeks
|
273.00
|
MEDIUM
|
289.00
|
FAVORABLE
|
|
|
|
May 12th, 2022 06:03AM
|
May 12th, 2022 06:03AM
|
Health Care
|
Pharmaceuticals & Biotechnology
|